Murine mesenchymal progenitor cells from different tissues differentiated via mesenchymal microspheres into the...

Area of Science:

• Stem cell biology
• Cellular differentiation
• Tissue engineering

Background:

• Phenotypical identification of mesenchymal stem and progenitor cells lacks specific markers.
• Assessing in vitro differentiation capacity is crucial for cell characterization.
• Classical differentiation protocols are often cell-consuming and time-intensive.

Purpose of the Study:

• To demonstrate the practicability of a novel differentiation test for plastic-adherent cell isolates.
• To establish a time- and cell-saving screening method for adult progenitor cell differentiation.
• To analyze multilineage differentiation properties in a three-dimensional system.

Main Methods:

• Introduction of the mesenchymal microsphere method for 3D cell culture.
• Isolation and characterization of mesenchymal progenitor cells from murine perirenal adipose and mediastinal stromal tissues.
• Comparison with bone marrow progenitor cells, assessing proliferation via daily doubling index.
• Analysis of multilineage differentiation using the mesenchymal microsphere, micro mass body, and monolayer protocols.
• Characterization of differentiation via histochemical, immunohistochemical staining, and RT-PCR.

Main Results:

• The mesenchymal microsphere method proved feasible for screening multilineage differentiation.
• New sources of adult murine mesenchymal progenitor cells were identified and characterized.
• All cell isolates demonstrated capacity for chondrogenic, osteogenic, and adipogenic differentiation.
• Flow cytometry revealed differences in CD marker expression among undifferentiated cells.
• The mesenchymal microsphere method requires approximately 7 times fewer cells than classical protocols.

Conclusions:

• The mesenchymal microsphere method is an efficient test system for evaluating chondro-, osteo-, and adipogenic differentiation of adult progenitor cells.
• This novel method significantly reduces cell number requirements compared to traditional protocols.
• The new differentiation method has the potential to save time and cells in future clinical applications involving human mesenchymal stromal cells.